EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. (Q46113744)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Kentaro Inamura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Yuki Togashi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Satoko Hatano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hironori Ninomiya

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Noriko Motoi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ming-yon Mun

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yukinori Sakao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sakae Okumura

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ken Nakagawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Manabu Soda

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Young Lim Choi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hiroyuki Mano

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yuichi Ishikawa

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

20 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

508-515

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19234440%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.2

22 January 2020

exact match

0 references

cites work

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Up-regulation of PTEN at the transcriptional level is an adverse prognostic factor in female lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

EGFR mutation is specific for terminal respiratory unit type adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2

inferred from DOI database lookup

7 January 2021

based on heuristic

KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.2